Stay updated on PD-L1+ NSCLC Clinical Trial: Pembrolizumab Combo

Sign up to get notified when there's something new on the PD-L1+ NSCLC Clinical Trial: Pembrolizumab Combo page.
Latest website image capture
Clouds background image

Latest updates to the PD-L1+ NSCLC Clinical Trial: Pembrolizumab Combo page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Plain Language Summary was removed from the study page, eliminating the layperson-friendly overview of the trial and its objectives.
    Difference
    0.0%
    Check dated 2026-08-16T15:33:55.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    An HTML error page was added, making the study record unavailable. Several core content sections and sponsor/IPD-related items were removed from the page, reducing the information available about the study.
    Difference
    17%
    Check dated 2026-08-09T08:57:49.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.3 to v3.6.4. This indicates an internal update to the page's metadata rather than any changes to the study content.
    Difference
    0.0%
    Check dated 2026-07-25T16:42:27.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.2 to v3.6.3, indicating a new published revision of the record. This appears to be a small, internal version update with no visible changes to the study details or data.
    Difference
    0.0%
    Check dated 2026-07-04T04:17:48.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.0 to v3.6.2, signaling a newer software patch for the study record; there are no described content changes in this update.
    Difference
    0.0%
    Check dated 2026-06-27T02:48:41.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    New help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment section was updated; the heading was normalized from 'Intervention / Treatment' to 'Intervention/Treatment' and the revision tag updated to v3.6.0 from v3.5.5. A note states that no participants are being recruited anymore, indicating enrollment is closed.
    Difference
    0.3%
    Check dated 2026-06-12T17:32:40.000Z thumbnail image

Stay in the know with updates to PD-L1+ NSCLC Clinical Trial: Pembrolizumab Combo

Enter your email address, and we'll notify you when there's something new on the PD-L1+ NSCLC Clinical Trial: Pembrolizumab Combo page.